OLAPARIB | OLAPARIB | ATC L01XX46
ANTINEOPLASTIC POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR TREATMENT OF OVARIAN CANCER | ORAL | Tmax 2 HOUR VD 167 LITER PPB 82 PERCENT Cl 8.6 LITER / HOUR HT 11.9 HOUR SOLUBILITY PH-INDEPENDENT LOW SOLUBILITY OF APPROXIMATELY 0.1 MILLIGRAM / MILLILITER ACROSS THE PHYSIOLOGICAL PH RANGE | TANKYRASE 2 PDB 5DS3 (CRYSTAL STRUCTURE OF CONSTITUTIVELY ACTIVE PARP-1) LIGAND CODE = 09L (link to the list of PDB complexes) Download experimental 3D coordinates of 09L with added hydrogens | PARP 1, 2 & 3 INHIBITOR CHEMBL3390820 PARP 1, 2 AND 3 P09874 POLY [ADP-RIBOSE] POLYMERASE 1 HOMO SAPIENS ENZYME | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |